Bionexus Gene Lab Corp. (BGLC)
NASDAQ · Basic Materials
Bionexus Gene Lab Corp. Shareholder Equity 2018–2025
Bionexus Gene Lab Corp. annual shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Bionexus Gene Lab Corp. shareholder equity as of December 31, 2025: 8.6M, a 3.51% increase year-over-year.
- Bionexus Gene Lab Corp. shareholder equity for 2025 were 8.6M, a 3.51% increase from 2024.
- Bionexus Gene Lab Corp. shareholder equity for 2024 were 8.3M, a 13.82% decrease from 2023.
- Bionexus Gene Lab Corp. shareholder equity for 2023 were 9.7M, a 44.90% increase from 2022.
- Bionexus Gene Lab Corp. shareholder equity for 2022 were 6.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Bionexus Gene Lab Corp. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $9 |
| 2024 | $8 |
| 2023 | $10 |
| 2022 | $7 |
| 2021 | $7 |
| 2020 | $7 |
| 2019 | $1 |
| 2018 | $2 |
Bionexus Gene Lab Corp. Shareholder Equity — FAQ
Bionexus Gene Lab Corp. (BGLC) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BGLC's shareholder equity history?
The chart and table above show Bionexus Gene Lab Corp.'s shareholder equity by year and by quarter, including the growth rate.